INS and atherosclerosis: Moreover, mice treated with antisense oligonucleotides (ASOs) targeting ANGPTL3 messenger RNA (mRNA) manifested dose-dependent reductions in LDL cholesterol, TRG, atherosclerosis progression, and liver TRG content and an increase in insulin sensitivity [75].